<DOC>
	<DOCNO>NCT02203656</DOCNO>
	<brief_summary>The purpose study test feasibility intervention accelerate recovery muscle mass function old adult follow acute hospitalization .</brief_summary>
	<brief_title>Feasibility Study Post-hospitalization Interventions Improve Physical Function Older Adults</brief_title>
	<detailed_description>The purpose study test feasibility intervention accelerate recovery muscle mass function old adult follow acute hospitalization</detailed_description>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Admitted University Texas Medical Branch ( UTMB ) ACE unit admit diagnosis congestive heart failure , respiratory infection , kidney/urinary tract infection , metabolic disorder ; condition allow subject participate study patient review Aged 65 year older Selfreported ability ( without aid assistive device ) walk across small room two week prior hospitalization Lives within 30 mile UTMB Can stand without assistance time pretesting Presents medical contraindication wear loose fitting velcro strap accelerometer one ankle Score ≥26 30item Mini Mental State Examination alert orient X3 physician H &amp; P Is discharge `` home '' ACE unit discharge . Nursing home resident hospice patient Uncontrolled blood pressure ( systolic &gt; 150 , diastolic &gt; 100 ) History stroke motor disability Glomerular filtration rate ( GFR ) &lt; 30 mL/min/1.73m2 evidence kidney disease failure Liver disease ( aspartate aminotransferase ( AST ) /Alanine transaminase ( ALT ) 2 time normal limit , hyperbilirubinemia ) Recent ( within 3 month ) treatment anabolic steroid Any condition event consider exclusionary PI faculty physician Planned elective hospitalization within 30 day discharge Additional Exclusion Criteria Subjects Randomized Testosterone Group Breast prostate cancer Palpable prostate nodule induration prostate specific antigen ( PSA ) ≥ 4 ng/ml PSA ≥ 3 ng/ml men high risk prostate cancer , African Americans men firstdegree relative prostate cancer Hematocrit ≥ 50 % Decompensated heart failure determine physician</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>intervention study</keyword>
	<keyword>nutrition</keyword>
	<keyword>exercise</keyword>
	<keyword>testosterone</keyword>
	<keyword>patient readmission</keyword>
</DOC>